Plasmapheresis treatment of antibody-mediated rejection in an A2 donor to O pediatric liver transplant recipient

Pediatr Transplant. 2011 Feb;15(1):E15-8. doi: 10.1111/j.1399-3046.2009.01224.x.

Abstract

It is safe to transplant kidneys from blood group A2 donors into O recipients if the latter have low titers of anti-A antibodies. However, in liver transplantation, O and B recipients of A2 donor livers are not routinely screened for anti-blood group antibodies because of the immuno-absorptive capacity of the liver and the low incidence of antibody-mediated rejection. Herein, we report a rare case of combined cell and antibody-mediated rejection in a pediatric blood group O recipient of an A2 donor liver, and rescue of the allograft using PP and IVIG.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Biopsy
  • Blood Group Incompatibility
  • End Stage Liver Disease / therapy*
  • Female
  • Graft Rejection
  • Humans
  • Immunity, Humoral
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Inflammation
  • Ischemia
  • Liver Transplantation / methods*
  • Plasmapheresis / methods*
  • Transplantation, Homologous / methods

Substances

  • Immunosuppressive Agents